First delivery of Astatine-211 in Belgium!

An important milestone has been reached with the first delivery of Astatine-211, produced by the Forschungszentrum Jülich and swiftly transported in just one day thanks to TetraKit Technologies, for calibration activities ahead of upcoming preclinical and clinical studies.

These studies will be conducted in collaboration with SCK CEN, Université libre de Bruxelles, and Institut Jules Bordet, paving the way for the development of new approaches in nuclear medicine and targeted alpha therapies.

A great example of European scientific collaboration driving innovation and translational research forward.